Proceedings of the Second International Symposium on Helicobacter pylori Bad Nauheim, August 25¿26th, 1989 Herausgegeben von Menge, Heinz; Gregor, M.; Tytgat, Guido N.J.; Marshall, Barry J.; McNulty, Cliodna A.M.
Proceedings of the Second International Symposium on Helicobacter pylori Bad Nauheim, August 25¿26th, 1989 Herausgegeben von Menge, Heinz; Gregor, M.; Tytgat, Guido N.J.; Marshall, Barry J.; McNulty, Cliodna A.M.
Bei der Entstehung von Magengeschw}ren ist in den letzten Jahren die Bedeutung einer Ausl sung durch Campylobacter pylori bekannt geworden. Neue systematische Untersuchungen f}hrten zu einer Namens{nderung: Helicobacter. Der Band gibt eine Õbersicht }ber den derzeitigen Wissensstand.
Bei der Entstehung von Magengeschw}ren ist in den letzten Jahren die Bedeutung einer Ausl sung durch Campylobacter pylori bekannt geworden. Neue systematische Untersuchungen f}hrten zu einer Namens{nderung: Helicobacter. Der Band gibt eine Õbersicht }ber den derzeitigen Wissensstand.
Section 1 Virulence Factors and Pathogenicity of Helicobacter pylori.- Urease and Catalase as Virulence Factors of Helicobacter pylori.- Discussion.- Adhesion Properties of Helicobacter pylori.- Helicobacter pylori Hemagglutinins.- Discussion.- Cytotoxic Activity of Helicobacter pylori.- Discussion.- Helicobacter pylori and Gastric Mucus Integrity.- Discussion.- Helicobacter pylori and Other Gastric Spirilla: Similarities and Differences.- Further Observations on Human Spirobacteria.- Discussion.- Animal Models of Helicobacter pylori Gastritis.- Discussion.- Isotype and Specificity of Local and Systemic Anti-Helicobacter pylori Antibodies.- Discussion.- Section 2 Epidemiology of Helicobacter pylori.- Survival of Helicobacter pylori in the Aquatic Environment.- Discussion.- Helicobacter pylori in Human Populations: The Present and Predictions of the Future Based on the Epidemiology of Polio.- Discussion.- Transmission and Sources of Helicobacter pylori.- Discussion.- Chronic Gastritis: Epidemiology and Relationship to Peptic Ulcer Diseases.- Gastritis Epidemiology and Natural History.- Discussion.- Epidemiology of Gastric Metaplasia.- Discussion.- Epidemiology of Duodenal Ulcer Disease.- Discussion.- Section 3 Theoretical Site of Helicobacter pylori Therapy.- In Vitro Sensitivity of Helicobacter pylori.- Discussion.- Antibiotic Concentrations in Gastric Mucosa: The Guinea Pig Model.- Discussion.- Acquired Resistance to Antibiotics: An Underestimated Cause of Failure in the Treatment of Helicobacter pylori Infection.- Discussion.- Clinical Pharmacology of Bismuth - Studies from the Royal Free Hospital.- The Absorption of Bismuth from Orally Administered Tripotassium Dicitrato Bismuthate and Bismuth Subsalicylate.- Pharmacokinetics of Bismuth Compounds in Patients with Gastritis and Ulcer Disease During Standard Treatment.- Discussion.- Pharmacology and Safety of Bismuth Compounds.- Discussion.- Section 4 Clinical Trials for Helicobacter pylori Treatment.- Treatment Regimens to Eradicate Helicobacter pylori.- Discussion.- Effect of Eradication of Helicobacter pylori on Nonulcer Dyspepsia Syndrome and Chronic Gastritis.- Discussion.- Section 5 Optimal Design of Clinical Trials.- Histological Definition and Scoring of Gastritis.- Discussion.- Measuring Symptoms in Helicobacter pylori-Associated Gastritis and Non-Ulcer Dyspepsia.- Discussion.- Optimal Study Design for Therapeutic Trials in Helicobacter pylori- Associated Nonulcer Dyspepsia.- Discussion.- Optimal Design for Peptic Ulcer Studies.- Discussion.
Section 1 Virulence Factors and Pathogenicity of Helicobacter pylori.- Urease and Catalase as Virulence Factors of Helicobacter pylori.- Discussion.- Adhesion Properties of Helicobacter pylori.- Helicobacter pylori Hemagglutinins.- Discussion.- Cytotoxic Activity of Helicobacter pylori.- Discussion.- Helicobacter pylori and Gastric Mucus Integrity.- Discussion.- Helicobacter pylori and Other Gastric Spirilla: Similarities and Differences.- Further Observations on Human Spirobacteria.- Discussion.- Animal Models of Helicobacter pylori Gastritis.- Discussion.- Isotype and Specificity of Local and Systemic Anti-Helicobacter pylori Antibodies.- Discussion.- Section 2 Epidemiology of Helicobacter pylori.- Survival of Helicobacter pylori in the Aquatic Environment.- Discussion.- Helicobacter pylori in Human Populations: The Present and Predictions of the Future Based on the Epidemiology of Polio.- Discussion.- Transmission and Sources of Helicobacter pylori.- Discussion.- Chronic Gastritis: Epidemiology and Relationship to Peptic Ulcer Diseases.- Gastritis Epidemiology and Natural History.- Discussion.- Epidemiology of Gastric Metaplasia.- Discussion.- Epidemiology of Duodenal Ulcer Disease.- Discussion.- Section 3 Theoretical Site of Helicobacter pylori Therapy.- In Vitro Sensitivity of Helicobacter pylori.- Discussion.- Antibiotic Concentrations in Gastric Mucosa: The Guinea Pig Model.- Discussion.- Acquired Resistance to Antibiotics: An Underestimated Cause of Failure in the Treatment of Helicobacter pylori Infection.- Discussion.- Clinical Pharmacology of Bismuth - Studies from the Royal Free Hospital.- The Absorption of Bismuth from Orally Administered Tripotassium Dicitrato Bismuthate and Bismuth Subsalicylate.- Pharmacokinetics of Bismuth Compounds in Patients with Gastritis and Ulcer Disease During Standard Treatment.- Discussion.- Pharmacology and Safety of Bismuth Compounds.- Discussion.- Section 4 Clinical Trials for Helicobacter pylori Treatment.- Treatment Regimens to Eradicate Helicobacter pylori.- Discussion.- Effect of Eradication of Helicobacter pylori on Nonulcer Dyspepsia Syndrome and Chronic Gastritis.- Discussion.- Section 5 Optimal Design of Clinical Trials.- Histological Definition and Scoring of Gastritis.- Discussion.- Measuring Symptoms in Helicobacter pylori-Associated Gastritis and Non-Ulcer Dyspepsia.- Discussion.- Optimal Study Design for Therapeutic Trials in Helicobacter pylori- Associated Nonulcer Dyspepsia.- Discussion.- Optimal Design for Peptic Ulcer Studies.- Discussion.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
